|
|
|
|
|
|
|
|
|
|
Previous: PHARMACEUTICAL PRODUCT DEVELOPMENT INC, 10-Q, EX-10.154, 2000-11-13 |
Next: LCA VISION INC, 10-Q, 2000-11-13 |
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extended from the
Pharmaceutical Product Development Inc. Consolidated Balance Sheet and Statement
of Operation included within this Form 10-Q and is quailfied in its entirety by
reference to such financial statements.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-2000
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 73,597
<SECURITIES> 0
<RECEIVABLES> 116,784
<ALLOWANCES> 1,196
<INVENTORY> 0
<CURRENT-ASSETS> 210,720
<PP&E> 122,966
<DEPRECIATION> 64,585
<TOTAL-ASSETS> 312,265
<CURRENT-LIABILITIES> 90,939
<BONDS> 0
0
0
<COMMON> 2,505
<OTHER-SE> 215,504
<TOTAL-LIABILITY-AND-EQUITY> 312,265
<SALES> 0
<TOTAL-REVENUES> 225,080
<CGS> 0
<TOTAL-COSTS> 130,642
<OTHER-EXPENSES> 93,820
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 490
<INCOME-PRETAX> 35,637
<INCOME-TAX> 13,294
<INCOME-CONTINUING> 22,343
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 22,343
<EPS-BASIC> 0.90
<EPS-DILUTED> 0.89
</TABLE>
|
|